| Dr Sungtae Lim, MD | |
|
210 Ark Rd, Mount Laurel, NJ 08054-3188 | |
| (856) 778-8860 | |
| (609) 261-4180 |
| Full Name | Dr Sungtae Lim |
|---|---|
| Gender | Male |
| Speciality | Diagnostic Radiology |
| Experience | 31 Years |
| Location | 210 Ark Rd, Mount Laurel, New Jersey |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1184626582 | NPI | - | NPPES |
| 8238201 | Medicaid | NJ |
| Facility Name | Location | Facility Type |
|---|---|---|
| Virtua Memorial Hospital Of Burlington County | Mount holly, NJ | Hospital |
| Virtua West Jersey Hospitals | Voorhees, NJ | Hospital |
| Virtua Willingboro Hospital | Willingboro, NJ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Larchmont Imaging Associates Llc | 5193762433 | 23 |
| Radiology Associates Of Burlington County, P.a. | 7012954381 | 56 |
| South Jersey Radiology Associates, P.a. | 9133115587 | 60 |
News Archive
The National Marrow Donor Program today applauded the introduction of the "Stem Cell Therapeutic and Research Reauthorization Act of 2010." Sens. Orrin Hatch (R-UT), Christopher Dodd (D-CT), Richard Burr (R-NC), Jack Reed (D-RI), John Ensign (R-NV), and Al Franken (D-MN) introduced the act in the U.S. Senate as S. 3751 on Thursday, Aug. 5. Last evening, Reps. C.W. Bill Young (R-FL) and Doris Matsui (D-CA) introduced the companion legislation, (H.R. 6081), in the House.
NPS Pharmaceuticals, Inc. (NASDAQ: NPSP), a global biopharmaceutical company pioneering and delivering therapies that transform the lives of patients with rare diseases worldwide, today announced that the company has initiated a global registration study of teduglutide in pediatric patients with Short Bowel Syndrome (SBS) who are dependent on parenteral support.
Great strides have been made in treating neuroblastoma, the most common cancer in infants and toddlers. However, advanced cases are often fatal, and children who survive often face life-long physical and intellectual challenges related to their treatment.
Patients undergoing percutaneous coronary intervention (PCI), a coronary artery widening procedureused to treat heart disease, are at high risk for obstructive sleep apnea (OSA), according to new research presented at the 2015 American Thoracic Society International Conference.
› Verified 3 days ago
| Entity Name | South Jersey Radiology Associates, P.a. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1477551653 PECOS PAC ID: 9133115587 Enrollment ID: O20040422000102 |
News Archive
The National Marrow Donor Program today applauded the introduction of the "Stem Cell Therapeutic and Research Reauthorization Act of 2010." Sens. Orrin Hatch (R-UT), Christopher Dodd (D-CT), Richard Burr (R-NC), Jack Reed (D-RI), John Ensign (R-NV), and Al Franken (D-MN) introduced the act in the U.S. Senate as S. 3751 on Thursday, Aug. 5. Last evening, Reps. C.W. Bill Young (R-FL) and Doris Matsui (D-CA) introduced the companion legislation, (H.R. 6081), in the House.
NPS Pharmaceuticals, Inc. (NASDAQ: NPSP), a global biopharmaceutical company pioneering and delivering therapies that transform the lives of patients with rare diseases worldwide, today announced that the company has initiated a global registration study of teduglutide in pediatric patients with Short Bowel Syndrome (SBS) who are dependent on parenteral support.
Great strides have been made in treating neuroblastoma, the most common cancer in infants and toddlers. However, advanced cases are often fatal, and children who survive often face life-long physical and intellectual challenges related to their treatment.
Patients undergoing percutaneous coronary intervention (PCI), a coronary artery widening procedureused to treat heart disease, are at high risk for obstructive sleep apnea (OSA), according to new research presented at the 2015 American Thoracic Society International Conference.
› Verified 3 days ago
| Entity Name | Larchmont Imaging Associates Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1710932603 PECOS PAC ID: 5193762433 Enrollment ID: O20050408000523 |
News Archive
The National Marrow Donor Program today applauded the introduction of the "Stem Cell Therapeutic and Research Reauthorization Act of 2010." Sens. Orrin Hatch (R-UT), Christopher Dodd (D-CT), Richard Burr (R-NC), Jack Reed (D-RI), John Ensign (R-NV), and Al Franken (D-MN) introduced the act in the U.S. Senate as S. 3751 on Thursday, Aug. 5. Last evening, Reps. C.W. Bill Young (R-FL) and Doris Matsui (D-CA) introduced the companion legislation, (H.R. 6081), in the House.
NPS Pharmaceuticals, Inc. (NASDAQ: NPSP), a global biopharmaceutical company pioneering and delivering therapies that transform the lives of patients with rare diseases worldwide, today announced that the company has initiated a global registration study of teduglutide in pediatric patients with Short Bowel Syndrome (SBS) who are dependent on parenteral support.
Great strides have been made in treating neuroblastoma, the most common cancer in infants and toddlers. However, advanced cases are often fatal, and children who survive often face life-long physical and intellectual challenges related to their treatment.
Patients undergoing percutaneous coronary intervention (PCI), a coronary artery widening procedureused to treat heart disease, are at high risk for obstructive sleep apnea (OSA), according to new research presented at the 2015 American Thoracic Society International Conference.
› Verified 3 days ago
| Entity Name | Radiology Associates Of Burlington County, P.a. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1255385183 PECOS PAC ID: 7012954381 Enrollment ID: O20050408000763 |
News Archive
The National Marrow Donor Program today applauded the introduction of the "Stem Cell Therapeutic and Research Reauthorization Act of 2010." Sens. Orrin Hatch (R-UT), Christopher Dodd (D-CT), Richard Burr (R-NC), Jack Reed (D-RI), John Ensign (R-NV), and Al Franken (D-MN) introduced the act in the U.S. Senate as S. 3751 on Thursday, Aug. 5. Last evening, Reps. C.W. Bill Young (R-FL) and Doris Matsui (D-CA) introduced the companion legislation, (H.R. 6081), in the House.
NPS Pharmaceuticals, Inc. (NASDAQ: NPSP), a global biopharmaceutical company pioneering and delivering therapies that transform the lives of patients with rare diseases worldwide, today announced that the company has initiated a global registration study of teduglutide in pediatric patients with Short Bowel Syndrome (SBS) who are dependent on parenteral support.
Great strides have been made in treating neuroblastoma, the most common cancer in infants and toddlers. However, advanced cases are often fatal, and children who survive often face life-long physical and intellectual challenges related to their treatment.
Patients undergoing percutaneous coronary intervention (PCI), a coronary artery widening procedureused to treat heart disease, are at high risk for obstructive sleep apnea (OSA), according to new research presented at the 2015 American Thoracic Society International Conference.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Sungtae Lim, MD 1295 Route 38, P.o. Box 479, Hainesport, NJ 08036-2702 Ph: (609) 261-7017 | Dr Sungtae Lim, MD 210 Ark Rd, Mount Laurel, NJ 08054-3188 Ph: (856) 778-8860 |
News Archive
The National Marrow Donor Program today applauded the introduction of the "Stem Cell Therapeutic and Research Reauthorization Act of 2010." Sens. Orrin Hatch (R-UT), Christopher Dodd (D-CT), Richard Burr (R-NC), Jack Reed (D-RI), John Ensign (R-NV), and Al Franken (D-MN) introduced the act in the U.S. Senate as S. 3751 on Thursday, Aug. 5. Last evening, Reps. C.W. Bill Young (R-FL) and Doris Matsui (D-CA) introduced the companion legislation, (H.R. 6081), in the House.
NPS Pharmaceuticals, Inc. (NASDAQ: NPSP), a global biopharmaceutical company pioneering and delivering therapies that transform the lives of patients with rare diseases worldwide, today announced that the company has initiated a global registration study of teduglutide in pediatric patients with Short Bowel Syndrome (SBS) who are dependent on parenteral support.
Great strides have been made in treating neuroblastoma, the most common cancer in infants and toddlers. However, advanced cases are often fatal, and children who survive often face life-long physical and intellectual challenges related to their treatment.
Patients undergoing percutaneous coronary intervention (PCI), a coronary artery widening procedureused to treat heart disease, are at high risk for obstructive sleep apnea (OSA), according to new research presented at the 2015 American Thoracic Society International Conference.
› Verified 3 days ago
Dr. Howard S. Berinson, M.D. Radiology Medicare: Medicare Enrolled Practice Location: 210 Ark Rd, Mount Laurel, NJ 08054 Phone: 856-261-4500 Fax: 609-261-4180 | |
Dr. Nick Maravich, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 210 Ark Rd, Mount Laurel, NJ 08054 Phone: 856-778-8860 Fax: 609-261-4180 | |
Dr. Robert T. Harvey, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 210 Ark Rd, Mount Laurel, NJ 08054 Phone: 856-778-8860 Fax: 609-261-4180 | |
Dr. Britton Miller Chan, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 210 Ark Road, Mount Laurel, NJ 08054 Phone: 609-914-7017 | |
Dr. Priyesh Patel, M.D. Radiology Medicare: May Accept Medicare Assignments Practice Location: 210 Ark Rd, Mount Laurel, NJ 08054 Phone: 609-261-4500 Fax: 609-261-4180 | |
Dr. Kevin P. Barry, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 210 Ark Rd, Mount Laurel, NJ 08054 Phone: 856-778-8860 Fax: 609-261-4180 |